All Pharma News
eFFECTOR, Dana-Farber To Study Zotatifin ER+ Endo/Ovarian Cancer Combo

eFFECTOR, Dana-Farber To Study Zotatifin ER+ Endo/Ovarian Cancer Combo
GLOBENEWSWIRE
20 May 2024
Share Share
Dana-Farber’s computer platform makes patient matching process easier

Dana-Farber’s computer platform makes patient matching process easier
CLINICALTRIALSARENA
14 Oct 2022
Share Share
Dana-Farber CEO Laurie Glimcher resigns from GSK board

Dana-Farber CEO Laurie Glimcher resigns from GSK board
Zachary Brennan ENDPTS
29 Jul 2022
Share Share
Novel cancer vaccines look beyond T cells to better fight tumors

Novel cancer vaccines look beyond T cells to better fight tumors
Angus Liu FIERCEBIOTECH
27 May 2022
Share Share
Varsity Pharmaceuticals Licenses Pol-Theta Inhibitor

Varsity Pharmaceuticals Licenses Pol-Theta Inhibitor
BUSINESSWIRE
07 Feb 2022
Share Share
BAKX nets more cash for its `Thelma and Louise` approach to cancer cell death

BAKX nets more cash for its `Thelma and Louise` approach to cancer cell death
Nicole DeFeudis ENDPTS
18 Nov 2021
Share Share
Eureka Initiates Phase I/II ARYA-2 Trial of ET140203 ARTEMIS T Cells

Eureka Initiates Phase I/II ARYA-2 Trial of ET140203 ARTEMIS T Cells
BUSINESSWIRE
17 Nov 2021
Share Share
Lew Cantley is headed to Dana-Farber

Lew Cantley is headed to Dana-Farber
John Carroll ENDPTS
11 Nov 2021
Share Share
Renowned Dana-Farber scientist, David Livingston has died

Renowned Dana-Farber scientist, David Livingston has died
John Carroll ENDPTS
20 Oct 2021
Share Share
Luba Greenwood takes the helm at Kojin Therapeutics; Alexion R&D chief packs up

Luba Greenwood takes the helm at Kojin Therapeutics; Alexion R&D chief packs up
Alex Hoffmann ENDPTS
15 Oct 2021
Share Share